Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Oral vs Sublingual PK in Liver Transplant
NCT02608606Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of tacrolimus + Wuzhi capsule in Liver transplant rejection (2 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Area Under the Curve at 30 days. Started Mar 2015; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT02608606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608606.